• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受血液透析的系统性红斑狼疮患者发生血管通路血栓形成的风险

Risk of vascular access thrombosis in patients with systemic lupus erythematosus on hemodialysis.

作者信息

Shafi S T, Gupta M

机构信息

Division of Nephrology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

出版信息

J Vasc Access. 2007 Apr-Jun;8(2):103-8.

PMID:17534796
Abstract

INTRODUCTION

Anticardiolipin antibody is associated with increased risk of vascular access thrombosis (VAT) in hemodialysis (HD) patients. Systemic lupus erythematous (SLE) patients have a high prevalence of anticardiolipin antibodies, but it is not clear whether these patients are at high risk of developing vascular access thrombosis.

METHODS

Thirty six SLE patients on HD, who had either an arterio-venous (AV) graft or AV fistula as vascular access, and were not on anticoagulation treatment, were retrospectively identified at Henry Ford Hospital. A similar number of patients without SLE, matched for age, sex, race and type of vascular access were selected as a control population. Vascular access thrombosis rate at one year was compared between two groups.

RESULTS

Mean age at dialysis was 36+/-10 years in 36 SLE patients (28 females, 8 males) and was 38+/-6.4 years in 36 non-SLE patients (29 females, 7 males). Of all patients, 29/36 (80.5%) SLE and 27/36 (75%) non-SLE patients had AV grafts, whereas the rest had AV fistulas as vascular access (19.5% SLE and 25% non-SLE patients). Out of 36 SLE patients, 24 (66.6%) patients developed VAT at one year as compared to 14 (38.9%) patients in non-SLE group (p<0.05). The odds ratio of VAT in SLE patients was 3.1 (95% CI 1.2-8.2).

CONCLUSION

SLE patients on hemodialysis are more likely to develop vascular access thrombosis as compared to non-SLE patients.

摘要

引言

抗心磷脂抗体与血液透析(HD)患者血管通路血栓形成(VAT)风险增加有关。系统性红斑狼疮(SLE)患者抗心磷脂抗体的患病率较高,但尚不清楚这些患者是否有发生血管通路血栓形成的高风险。

方法

在亨利福特医院对36例接受血液透析的SLE患者进行回顾性研究,这些患者以动静脉(AV)移植物或AV瘘作为血管通路,且未接受抗凝治疗。选择数量相似的无SLE患者作为对照人群,这些患者在年龄、性别、种族和血管通路类型方面相匹配。比较两组患者一年时的血管通路血栓形成率。

结果

36例SLE患者(28例女性,8例男性)透析时的平均年龄为36±10岁,36例非SLE患者(29例女性,7例男性)为38±6.4岁。所有患者中,29/36(80.5%)的SLE患者和27/36(75%)的非SLE患者有AV移植物,其余患者以AV瘘作为血管通路(SLE患者为19.5%,非SLE患者为25%)。36例SLE患者中,24例(66.6%)在一年时发生了VAT,而非SLE组为14例(38.9%)患者(p<0.05)。SLE患者发生VAT的比值比为3.1(95%CI 1.2 - 8.2)。

结论

与非SLE患者相比,接受血液透析的SLE患者更易发生血管通路血栓形成。

相似文献

1
Risk of vascular access thrombosis in patients with systemic lupus erythematosus on hemodialysis.接受血液透析的系统性红斑狼疮患者发生血管通路血栓形成的风险
J Vasc Access. 2007 Apr-Jun;8(2):103-8.
2
Clinical effectiveness of open thrombectomy for thrombosed autogenous arteriovenous fistulas and grafts.自体动静脉瘘和移植物血栓形成的开放式血栓切除术的临床效果。
J Vasc Surg. 2018 Jul;68(1):189-196. doi: 10.1016/j.jvs.2017.12.050. Epub 2018 Mar 8.
3
The influence of thrombophilic risk factors on vascular access survival in chronic dialysis patients in a retrospective evaluation.一项回顾性评估中血栓形成风险因素对慢性透析患者血管通路存活的影响。
Vasa. 2013 Jan;42(1):32-9. doi: 10.1024/0301-1526/a000245.
4
Outcome of the use of stent grafts to salvage failed arteriovenous accesses.使用覆膜支架挽救动静脉内瘘失败的结果。
Ann Vasc Surg. 2010 Jan;24(1):34-8. doi: 10.1016/j.avsg.2009.07.007. Epub 2009 Sep 17.
5
Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.血液透析患者的高同型半胱氨酸血症、抗心磷脂抗体状态与血管通路血栓形成风险
Kidney Int. 1999 Jan;55(1):315-20. doi: 10.1046/j.1523-1755.1999.00258.x.
6
The effect of implementation of an optimized care protocol on the outcome of arteriovenous hemodialysis access surgery.实施优化护理方案对动静脉血液透析通路手术结局的影响。
J Vasc Surg. 2008 Sep;48(3):659-68. doi: 10.1016/j.jvs.2008.04.002. Epub 2008 Jun 24.
7
Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study.系统性红斑狼疮所致终末期肾病患者与其他病因所致终末期肾病患者血管通路结局的比较:一项回顾性队列研究。
BMC Nephrol. 2016 Jul 7;17(1):64. doi: 10.1186/s12882-016-0274-y.
8
Effect of timing of thrombectomy on survival of thrombosed arteriovenous hemodialysis grafts.动静脉血液透析移植物血栓形成后取栓时机对其存活的影响。
Vasc Endovascular Surg. 2013 Jul;47(5):342-5. doi: 10.1177/1538574413487442. Epub 2013 Apr 30.
9
Surgical management of hemodialysis-related central venous occlusive disease: a treatment algorithm.血液透析相关中心静脉闭塞性疾病的外科治疗:一种治疗方案
Ann Vasc Surg. 2011 Jan;25(1):108-19. doi: 10.1016/j.avsg.2010.11.002.
10
Axillary loop grafts for hemodialysis access: midterm results from a single-center study.用于血液透析通路的腋部袢式移植物:单中心研究的中期结果
J Vasc Surg. 2008 Jan;47(1):138-43. doi: 10.1016/j.jvs.2007.09.059.

引用本文的文献

1
Long-term prognosis of vascular access in hemodialysis patients with systemic lupus erythematosus: a retrospective cohort study.系统性红斑狼疮血液透析患者血管通路的长期预后:一项回顾性队列研究。
Sci Rep. 2021 Jun 15;11(1):12519. doi: 10.1038/s41598-021-92005-5.
2
The outcome of the primary vascular access and its translation into prevalent access use rates in chronic haemodialysis patients.慢性血液透析患者的主要血管通路结局及其转化为常见通路使用率的情况。
Clin Kidney J. 2012 Aug;5(4):339-46. doi: 10.1093/ckj/sfs055. Epub 2012 Jun 28.
3
Improving outcomes in patients with lupus and end-stage renal disease.
改善狼疮和终末期肾病患者的治疗效果。
Semin Dial. 2013 Sep-Oct;26(5):590-6. doi: 10.1111/sdi.12122. Epub 2013 Sep 4.
4
Persistent low albumin and temporary vascular access in pediatric patients with SLE on hemodialysis.系统性红斑狼疮患儿血液透析时持续性低白蛋白血症及临时性血管通路情况
Pediatr Nephrol. 2009 Oct;24(10):1981-7. doi: 10.1007/s00467-009-1227-5. Epub 2009 Jun 13.